巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02367 巨子生物

未开盘 07-22 16:08:56

41.100

+1.200

+3.01%

最高42.450	最低39.750	成交量125.83万
今开39.900	昨收39.900	日振幅6.77%
总市值422.60亿	流通市值422.60亿	总股本10.28亿
成交额5,138万	换手率0.12%	流通股本10.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02367","market":"HK","secType":"STK","nameCN":"巨子生物","latestPrice":41.1,"timestamp":1721635736031,"preClose":39.9,"halted":0,"volume":1258328,"delay":0,"floatShares":1028220000,"shares":1028220000,"eps":1.5912874,"marketStatus":"未开盘","marketStatusCode":0,"change":1.2,"latestTime":"07-22 16:08:56","open":39.9,"high":42.45,"low":39.75,"amount":51380945,"amplitude":0.067669,"askPrice":41.15,"askSize":10000,"bidPrice":41.1,"bidSize":30600,"shortable":3,"etf":0,"ttmEps":1.583765538784018,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1667491200000,"adjPreClose":39.9,"dividendRate":0.011454,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.6310318542538847,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02367/tweets","defaultTab":"tweets","newsList":[{"id":"2453386297","title":"《大行》中金最新海外中资股策略首选组合(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2453386297","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453386297?lang=zh_cn&edition=full","pubTime":"2024-07-22 12:35","pubTimestamp":1721622900,"startTime":"0","endTime":"0","summary":"沽空资料截至 2024-07-22 12:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180503142123924_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180503142123924_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1365278/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00700","BK1528","LU0594300419.USD","BK1512","01810","01024","LU0594300179.USD","00780","00639","00883","82020","SG9999001051.SGD","LU0080751232.USD","09896","00285","00288","00941","LU1813983027.USD","03606","00968","81024","81810","BK1610","80700","LU0359202008.SGD","LU0516423174.USD","09992","00921","09926","02367","80883","02285","02020","IE00B5MMRT66.SGD","02018","03668","IE00B0169L03.USD","LU1794554557.SGD","XIACY","IE00B543WZ88.USD","HK0000306685.HKD","BK1594","HK0000306701.USD","02601","LU0029875118.USD","BK1095","02313","LU0054237671.USD","LU0181495838.USD","ANPDY"],"gpt_icon":1},{"id":"2452682446","title":"华泰证券商贸/轻工/纺服中期策略：消费回归理性 把握结构机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2452682446","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452682446?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:47","pubTimestamp":1721375269,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华泰证券发布商贸/轻工/纺服中期策略指出，产品力突出的国货借势渠道机遇持续提升份额，建议关注美妆/医美国货品牌。Q2受金价扰动、不改中期相对景气，板块估值调整至高性价比区间，建议关注品牌力强的头部珠宝企业。华泰证券主要观点如下：美护：时夏方长，正待新机1)美妆：渠道分化、国货势强、需求理性、产品创新是关键词。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1153121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1328277881.USD","LU1328615791.USD","02313","IE0008369823.USD","BK1502","BK1242","LU0314109678.HKD","BK1545","601688","BK1227","LU0181495838.USD","LU1813983027.USD","IE0008368742.USD","02145","LU0594300179.USD","02367","IE00B031HY20.USD","LU1064131003.USD","LU2148510915.USD","LU1934453819.USD","LU0359202008.SGD","LU1064130708.USD","LU1188198961.HKD","IE00BYTNYN87.SGD","LU0359201612.USD","LU0140636845.USD","BK0276","BK1521","LU0605514214.HKD","LU2125910500.SGD","LU0244354667.USD","BK1589","IE00BYQNZ168.SGD","IE00B29SXG58.USD","LU1781817850.SGD","LU2045819591.USD","BK0183","09896","BK1602","06969","LU1023057109.AUD","01929","LU0326950275.SGD","BK1249","BK1580","LU0594300419.USD","BK1207","IE0031814852.USD","SG9999011746.SGD","LU1831875114.USD"],"gpt_icon":0},{"id":"2451984807","title":"巨子生物7月15日获南向资金加仓118.16万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451984807","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451984807?lang=zh_cn&edition=full","pubTime":"2024-07-16 09:31","pubTimestamp":1721093498,"startTime":"0","endTime":"0","summary":"7月15日, 南向资金增持巨子生物118.16万股。截止当日收盘，港股通共持有巨子生物16261.60万股，占流通股15.81%。巨子生物近5个交易日下跌3.80%，港股通累计减持106.28万股；近20个交易日下跌15.64%，港股通累计减持358.21万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160940189f52baa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160940189f52baa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2451613851","title":"巨子生物(02367)出现大手卖出13.16万股，成交价$40.45，涉资532.322万","url":"https://stock-news.laohu8.com/highlight/detail?id=2451613851","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451613851?lang=zh_cn&edition=full","pubTime":"2024-07-15 16:08","pubTimestamp":1721030880,"startTime":"0","endTime":"0","summary":"[大手成交]巨子生物(02367)在下午04:08出现大手卖出，成交量为13.16万，成交价为港币$40.45，涉资532.322万。至目前为止，股价跌2.764%，今日最高价为$41.6，而最低价为$40.0，总成交量为348.02万股，总成交金额港币$1.405亿。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2407154060/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2451394650","title":"南向资金7月12日净卖出巨子生物55.18万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451394650","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451394650?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007096,"startTime":"0","endTime":"0","summary":"7月12日，南向资金减持巨子生物55.18万股连续3日减持。截止当日收盘，港股通共持有巨子生物16143.44万股，占流通股15.69%。巨子生物近5个交易日下跌2.69%，港股通累计减持214.62万股；近20个交易日下跌13.06%，港股通累计减持471.99万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509433995bd4221&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071509433995bd4221&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2450080573","title":"巨子生物07月12日主力资金流出1万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450080573","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450080573?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:15","pubTimestamp":1720772107,"startTime":"0","endTime":"0","summary":"07月12日, 巨子生物股价跌0.72%，报收41.60元，成交金额8768万元，换手率0.20%，振幅6.56%，量比0.62。巨子生物今日主力资金净流出1万元，连续3日净流出，上一交易日主力净流出1427万元，今日环比减少99.93%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为2.09%。该股近5个交易日下跌2.57%，主力资金累计净流入46万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1548万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121615189f3a5dca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121615189f3a5dca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2450616832","title":"港股概念追踪 |美妆市场国货崛起  机构看好头部企业渗透率提升（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2450616832","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450616832?lang=zh_cn&edition=full","pubTime":"2024-07-10 13:08","pubTimestamp":1720588122,"startTime":"0","endTime":"0","summary":"头部美护国货增长强势，市场份额持续上升。1)24H1美护国货头部品牌增速全面超越国际品牌。三大国际美妆公司23年在中国市场未能跑赢市场，各维度失速释放市场空间，印证国货崛起。申万宏源发布研报称，随着国货“质价比”上升，平价消费兴起，大众市场渗透率提升，利好大单品粘性强，渠道布局多元化的头部国货。玻尿酸产品组合带动收入提升，“海魅”进入快速放量上升通路。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02367","HSTECH","02145","BK1207","BK1574","BK1161","BK1593","YANG","HSCEI","06826","09939","07226","BK1515"],"gpt_icon":0},{"id":"2450235835","title":"巨子生物早盘涨近3% 财通证券维持“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2450235835","media":"新浪港股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450235835?lang=zh_cn&edition=full","pubTime":"2024-07-10 11:40","pubTimestamp":1720582809,"startTime":"0","endTime":"0","summary":"巨子生物（02367）早盘股价上涨2.58%，现报41.75港元，成交额6949.65万港元。\n　　财通证券发布研报表示，维持巨子生物“增持”评级，在美妆业务持续向好背景下，叠加医美械三产品获批预期，巨子有望实现美妆&医美业务“双重奏”，带动业绩、估值同步提升。预计2024-2026年收入分别为49.9/64.3/79.5亿元，归母净利润分别为19.9/25.3/31.2亿元，对应PE20/16/13倍。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-10/doc-inccrmwc6117532.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-07-10/doc-inccrmwc6117532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["02367"],"gpt_icon":0},{"id":"2450338738","title":"港股异动 | 巨子生物(02367)涨超3% 国货“质价比”上升 公司有望实现美妆&医美业务“双重奏”","url":"https://stock-news.laohu8.com/highlight/detail?id=2450338738","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450338738?lang=zh_cn&edition=full","pubTime":"2024-07-10 11:09","pubTimestamp":1720580971,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，巨子生物涨超3%，截至发稿，涨3.12%，报41.90港元，成交额6065.38万港元。该行指出，重组胶原蛋白赛道火热，助力公司品牌、品类快速发展，预计巨子生物24H1营收增速约43%，利润增速近33%。财通证券发布研报表示，维持巨子生物“增持”评级，在美妆业务持续向好背景下，叠加医美械三产品获批预期，巨子有望实现美妆&医美业务“双重奏”，带动业绩、估值同步提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1207","YANG","HSTECH","HSCEI","07226","02367"],"gpt_icon":0},{"id":"2450816358","title":"南向资金7月9日净买入巨子生物12.58万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816358","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450816358?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:31","pubTimestamp":1720575087,"startTime":"0","endTime":"0","summary":"7月9日, 南向资金增持巨子生物12.58万股，连续5日增持。截止当日收盘，港股通共持有巨子生物16380.45万股，占流通股15.92%。港股通增持金额前五个股分别为中国石油化工股份、工商银行、腾讯控股、速腾聚创、商汤-W。巨子生物近5个交易日下跌5.90%，港股通累计增持175.83万股；近20个交易日下跌20.04%，港股通累计减持223.29万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100942259f296156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407100942259f296156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2450967090","title":"申万宏源：渗透率持续提升叠加国货崛起 坚定看好化妆品医美板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2450967090","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450967090?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:44","pubTimestamp":1720514698,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，申万宏源发布研报称，随着国货“质价比”上升，平价消费兴起，大众市场渗透率提升，利好大单品粘性强，渠道布局多元化的头部国货。医美行业将持续受益于供给端产品丰富，行业规范化维持健康发展。头部美护国货增长强势，市场份额持续上升。1)24H1美护国货头部品牌增速全面超越国际品牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1147728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK1147","BK0183","06806","BK1207","BK1564","02367","02145","BK0012","000166","BK0276","BK0188"],"gpt_icon":0},{"id":"2450941700","title":"巨子生物07月09日获主力加仓1526万元 环比增加606.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450941700","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450941700?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:16","pubTimestamp":1720513010,"startTime":"0","endTime":"0","summary":"07月09日, 巨子生物股价跌3.21%，报收40.70元，成交金额1.99亿元，换手率0.48%，振幅6.18%，量比2.10。巨子生物今日主力资金净流入1526万元，上一交易日主力净流入216万元，今日环比增加606.48%。该股近5个交易日下跌5.66%，主力资金累计净流入2223万元；近20日主力资金累计净流入4117万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091617199f2422a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091617199f2422a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2450066775","title":"巨子生物(02367)下跌5.11%，报39.9元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450066775","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450066775?lang=zh_cn&edition=full","pubTime":"2024-07-09 13:11","pubTimestamp":1720501913,"startTime":"0","endTime":"0","summary":"7月9日，巨子生物(02367)盘中下跌5.11%，截至13:11，报39.9元/股，成交1.01亿元。巨子生物控股有限公司是一家专注于研发和生产重组胶原蛋白和稀有人参皂苷的高科技企业，主要业务包括功效性护肤品、医疗器械、功能性食品及特殊医学用途配方食品。公司拥有79项专利及专利申请，其重组胶原蛋白技术在中国获得行业内首个专利授权，并在2013年和2016年分别获得国家技术发明奖二等奖和中国专利金奖。截至2023年年报，巨子生物营业总收入35.24亿元、净利润14.52亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/09131141451640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2450069365","title":"巨子生物(02367)股价下跌5.113%，现价港币$39.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2450069365","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450069365?lang=zh_cn&edition=full","pubTime":"2024-07-09 13:11","pubTimestamp":1720501860,"startTime":"0","endTime":"0","summary":"[下跌股]巨子生物(02367) 股价在下午01:11比前收市价下跌5.113%，现股价为港币$39.9。至目前为止，今日最高价为$42.45，而最低价为$39.9。总成交量为247.92万股，总成交金额为港币$1.005亿。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407091132/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2449741338","title":"【券商聚焦】财通证券维持巨子生物(02367)“增持”评级 料公司净利将稳步提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2449741338","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449741338?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:35","pubTimestamp":1720420504,"startTime":"0","endTime":"0","summary":"金吾财讯｜财通证券发研报指，巨子生物发布618战报，双美妆品牌展现高增长势能。该行认为，美妆业务持续向好背景下，叠加医美械三产品获批预期，巨子有望实现美妆&医美业务“双重奏”，带动业绩、估值同步提升。该行预计2024-2026年收入分别为49.9/64.3/79.5亿元，归母净利润分别为19.9/25.3/31.2亿元，对应PE20/16/13倍，维持“增持”评级。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/MmVhZTZkMDM4NGVmNGFjNGI4NWVlMGI4Yzg3MDVjMjMzODE0Mjk0ODA4MTA0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MmVhZTZkMDM4NGVmNGFjNGI4NWVlMGI4Yzg3MDVjMjMzODE0Mjk0ODA4MTA0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1939962","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601108","02367"],"gpt_icon":0},{"id":"2449710173","title":"《大行》中金最新海外中资股策略首选组合(表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2449710173","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449710173?lang=zh_cn&edition=full","pubTime":"2024-07-08 12:32","pubTimestamp":1720413120,"startTime":"0","endTime":"0","summary":"中金发表港股策略报告表示，列出其最新海外中资股策略首选组合：股份│预测今年每股盈利变幅腾讯│+44.2%中移动│+9.6%中海油│+16.6%比亚迪电子│+25.7%中国太保│+20.3%小米-W│-20.5%海信家电│+19.9%万洲│+75.5%名创优品│+91.6%泡泡玛特│+36.9%巨子生物│+24.2%信义光能│+21.6%快手-W│+120%同程旅行│+23.9%兖煤澳大利亚│-11.8%安踏│+24.9%申洲│+21.9%瑞声│+92.5%首钢资源│+2.7%福耀玻璃│+16.1%康方生物│-118%泉峰控股│+272%(港股报价延迟最少十五分钟。沽空资料截至 2024-07-08 12:25。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190213145158652_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190213145158652_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1361964/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1144","LU0052750758.USD","LU0541502299.USD","80883","01024","LU2097828714.EUR","00921","LU2097828631.EUR","BK1580","02020","00639","03606","LU0979878070.USD","BK1582","82020","00968","02601","80700","02313","02367","09926","BK1607","02018","81810","LU1023057109.AUD","00285","00288","LU2097828474.EUR","00700","00883","LU0051755006.USD","09992","ANPDY","LU0048597586.USD","LU2097828557.USD","XIACY","02285","LU0702159699.USD","01810","81024","BK1149","00941","LU0320764599.SGD","LU0516423174.USD","09896","BK1608","00780","IE00B5MMRT66.SGD","03668","LU2097828805.USD"],"gpt_icon":0},{"id":"2449330713","title":"南向资金7月5日净买入巨子生物31.56万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449330713","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449330713?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:31","pubTimestamp":1720402281,"startTime":"0","endTime":"0","summary":"7月5日, 南向资金增持巨子生物31.56万股，连续3日增持。截止当日收盘，港股通共持有巨子生物16358.05万股，占流通股15.90%。港股通增持金额前五个股分别为建设银行、工商银行、中国移动、华晨中国、中国石油化工股份。巨子生物近5个交易日下跌2.73%，港股通累计增持152.94万股；近20个交易日下跌16.75%，港股通累计减持124.75万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080940459f1b6ab5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080940459f1b6ab5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0},{"id":"2449657239","title":"【券商聚焦】财通证券维持巨子生物(02367)“增持”评级 指其有望实现美妆&医美业务“双重奏”","url":"https://stock-news.laohu8.com/highlight/detail?id=2449657239","media":"腾讯自选股","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449657239?lang=zh_cn&edition=full","pubTime":"2024-07-05 14:33","pubTimestamp":1720161180,"startTime":"0","endTime":"0","summary":"我们预计2024-2026年收入分别为49.9/64.3/79.5亿元，归母净利润分别为19.9/25.3/31.2亿元，对应PE20/16/13倍，维持“增持”评级。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-07-05/doc-inccahni7452985.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-07-05/doc-inccahni7452985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["601108","02367"],"gpt_icon":0},{"id":"2448413654","title":"巨子生物(2367.HK)：618品牌业绩亮眼 期待注射产品进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2448413654","media":"中信建投证券","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448413654?lang=zh_cn&edition=full","pubTime":"2024-07-04 19:01","pubTimestamp":1720090909,"startTime":"0","endTime":"0","summary":"核心观点公司发布2024 年618 期间旗下品牌业绩，可复美及可丽金全渠道全周期GMV 分别同比增长60%+和100%+。简评618 品牌业绩亮眼，看好全年表现公司作为重组胶原蛋白行业龙头企业，618 期间主要品牌业绩表现优异，可复美核心产品在多项榜单蝉联TOP1，焦点及秩序等新品也持续发力，可丽金品牌增速亮眼，看好公司全年表现。两大主要品牌业绩亮眼。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041901569574a9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407041901569574a9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02367","BK1207"],"gpt_icon":0},{"id":"2448466715","title":"巨子生物7月3日获南向资金加仓81.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448466715","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448466715?lang=zh_cn&edition=full","pubTime":"2024-07-04 09:31","pubTimestamp":1720056695,"startTime":"0","endTime":"0","summary":"7月3日, 南向资金增持巨子生物81.72万股。截止当日收盘，港股通共持有巨子生物16286.35万股，占流通股15.83%。港股通增持金额前五个股分别为中国移动、工商银行、建设银行、招商银行、中国石油股份。巨子生物近5个交易日下跌4.22%，港股通累计减持67.30万股；近20个交易日下跌12.93%，港股通累计减持142.62万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040941549effcdd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407040941549effcdd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","02367"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xajuzi.com","stockEarnings":[{"period":"1week","weight":0.0161},{"period":"1month","weight":-0.1046},{"period":"3month","weight":-0.1242},{"period":"6month","weight":0.2266},{"period":"1year","weight":0.2673},{"period":"ytd","weight":0.1783}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"巨子生物控股有限公司是一家中国的投资控股公司。该公司通过其子公司主要从事基于生物活性材料的美容和健康产品的研发、生产和销售。该公司的主要产品包括功能性护肤品和医用敷料，其产品的关键生物活性成分为重组胶原蛋白。该公司还开发和生产基于人参皂苷技术的稀有功能食品。该公司主要在国内市场开展其业务。","exchange":"SEHK","name":"巨子生物","nameEN":"GIANT BIOGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"巨子生物,02367,巨子生物股票,巨子生物股票老虎,巨子生物股票老虎国际,巨子生物行情,巨子生物股票行情,巨子生物股价,巨子生物股市,巨子生物股票价格,巨子生物股票交易,巨子生物股票购买,巨子生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"巨子生物(02367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供巨子生物(02367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}